These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19208807)

  • 1. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis.
    Huang YH; Bao Y; Peng W; Goldberg M; Love K; Bumcrot DA; Cole G; Langer R; Anderson DG; Sawicki JA
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3426-30. PubMed ID: 19208807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts.
    He ZY; Wei XW; Luo M; Luo ST; Yang Y; Yu YY; Chen Y; Ma CC; Liang X; Guo FC; Ye TH; Shi HS; Shen GB; Wang W; Gong FM; He G; Yang L; Zhao X; Song XR; Wei YQ
    J Control Release; 2013 Dec; 172(3):679-89. PubMed ID: 24144916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
    Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
    Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
    Shang X; Lin X; Alvarez E; Manorek G; Howell SB
    Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the CLDN3 gene in ovarian cancer cells.
    Honda H; Pazin MJ; D'Souza T; Ji H; Morin PJ
    Cancer Biol Ther; 2007 Nov; 6(11):1733-42. PubMed ID: 17986852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
    Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
    Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer.
    Oh S; Yang H; Oh HR; Seo MR; Lee CH; Kim YH; Choi JY; Kim NY; Cheon GJ; Kang KW; Shin YK; Youn H
    Nucl Med Biol; 2022; 114-115():135-142. PubMed ID: 35501237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.
    Kwon MJ; Kim SS; Choi YL; Jung HS; Balch C; Kim SH; Song YS; Marquez VE; Nephew KP; Shin YK
    Carcinogenesis; 2010 Jun; 31(6):974-83. PubMed ID: 20053926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.
    Sun C; Yi T; Song X; Li S; Qi X; Chen X; Lin H; He X; Li Z; Wei Y; Zhao X
    Oncol Rep; 2011 Jul; 26(1):193-200. PubMed ID: 21519794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
    Lin X; Shang X; Manorek G; Howell SB
    PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ca
    Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
    Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration.
    Hicks DA; Galimanis CE; Webb PG; Spillman MA; Behbakht K; Neville MC; Baumgartner HK
    BMC Cancer; 2016 Oct; 16(1):788. PubMed ID: 27724921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo.
    Li CZ; Liu B; Wen ZQ; Li HY
    Folia Biol (Praha); 2008; 54(6):180-6. PubMed ID: 19393131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.
    Agarwal R; D'Souza T; Morin PJ
    Cancer Res; 2005 Aug; 65(16):7378-85. PubMed ID: 16103090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
    Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
    Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
    Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
    Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.
    Rangel LB; Agarwal R; D'Souza T; Pizer ES; Alò PL; Lancaster WD; Gregoire L; Schwartz DR; Cho KR; Morin PJ
    Clin Cancer Res; 2003 Jul; 9(7):2567-75. PubMed ID: 12855632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.